Clinical trial · Interventional
Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences
Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences: a Randomized Controlled Trial
NCT07694310CI-TRIAL-00120430not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study of current or former cancer patients will evaluate the effect of learning about uncertainties with the benefits of a new cancer drug on their hypothetical decisions to take the drug and their perceptions of the drug's effectiveness.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control | Other | — | UNRESOLVED |
| Limited study population | Other | — | UNRESOLVED |
| Multiple uncertainties | Other | — | UNRESOLVED |
| Small magnitude of effect | Other | — | UNRESOLVED |
| Unvalidates surrogate endpoint | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- type
- PLACEBO_COMPARATOR
- label
- Control
- description
- No uncertainty information
- interventionNames
- Other: Control
- type
- ACTIVE_COMPARATOR
- label
- Unvalidated surrogate endpoint
- description
- Zenova has only been shown to shrink the size of tumors. It is unknown whether Zenova improves how patients feel or how long they live.
- interventionNames
- Other: Unvalidates surrogate endpoint
- type
- ACTIVE_COMPARATOR
- label
- Limited study population
- description
- Zenova has not been studied in patients similar to Alex (patients with her race and ethnicity). It is unknown whether Zenova will work and what harms it will have for patients like her.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * US adults with a current or former cancer diagnosis (excluding nonmelanoma skin cancer), * 18 years of age and older * Fluent in English * Residing in the United States. Exclusion Criteria: * Adults who do not have a former cancer diagnosis or who were diagnosed with nonmelanoma skin cancer * Adults who complete the survey in under 150 seconds, and who do not meet the inclusion criteria.
References
Publications (0)
Data not yet available
No reference posted for this study.